Janardhan Herbs And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 05-07-2024
- Paid Up Capital ₹ 6.89 M
as on 05-07-2024
- Company Age 35 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 Cr
as on 05-07-2024
- Revenue 12.50%
(FY 2023)
- Profit 18.14%
(FY 2023)
- Ebitda 50.35%
(FY 2023)
- Net Worth 2.24%
(FY 2023)
- Total Assets 16.37%
(FY 2023)
About Janardhan Herbs And Research Centre
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.89 M.
The company currently has active open charges totaling ₹6.00 Cr.
Udita Goyal, Saumya Goyal, Anil Goyal, and One other member serve as directors at the Company.
- CIN/LLPIN
U20211UR1989PTC010583
- Company No.
010583
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Uttaranchal, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Janardhan Herbs And Research Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Udita Goyal  | Additional Director | 22-Mar-2015 | Current |
| Saumya Goyal | Additional Director | 22-Mar-2015 | Current |
| Anil Goyal | Director | 21-Mar-1989 | Current |
| Rashmi Goyal | Director | 21-Sep-1989 | Current |
Financial Performance and Corporate Structure Insights of Janardhan Herbs And Research Centre.
Janardhan Herbs And Research Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.5% increase. The company also saw a substantial improvement in profitability, with a 18.14% increase in profit. The company's net worth moved up by a moderate rise of 2.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Janardhan Herbs And Research Centre?
In 2023, Janardhan Herbs And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kwality Machines & Natural Gas Equipment Private LimitedActive 6 years 30 days
Anil Goyal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 27 Sep 2005 | ₹6.00 Cr | Open |
How Many Employees Work at Janardhan Herbs And Research Centre?
Unlock and access historical data on people associated with Janardhan Herbs And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Janardhan Herbs And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Janardhan Herbs And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
